Infinium Global Research Diabetes Drug Therapy Market | Page 3
According to the Asian diabetes prevention organization, below are the some of the key facts and figures related to Asia-
Pacific diabetes population:
60% of global diabetic population lives in Asia
9 million adults have diabetes in China, which represents 11.6% of adult population in the country
1 million adults live with diabetes in India
By 2030, it is estimated that both China and India combined will have almost half a billion diabetics
Asians have a higher percentage of body fat at the same BMI as whites
Almost 1 in 3 cigarettes manufactured around the globe is smoked in China
The Asia-Pacific diabetes drug therapy market includes a wide range of drug therapies used by healthcare professionals and
patients to treat their blood glucose levels. The key drivers of this market growth include growing number of diabetes
population, rise in base of geriatric population, large number of drugs under pipeline, need for new treatments with
improved efficacy and launch of new generation of products for the treatment. Growing demand from emerging markets and
supportive government initiatives are also been among foremost factors driving demand of diabetes drugs market.
Companies Profiled:
The report provides profiles of the companies in the Asia-Pacific diabetes drug therapy market such as, Abbott Laboratories,
Mannkind Corporation, Bristol Myers Squibb, Medtronic, AstraZeneca, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline,
Sanofi, Novo Nordisk, and Novartis International AG.
Make an Enquiry:-
https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/44
Report Highlights:
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this
report provides insights on the factors that are driving and restraining the Asia-Pacific diabetes drug therapy market.
Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new
market players can consider. The report provides insights into the market using analytical tools such as Porter’s five forces
analysis and DRO analysis of diabetes drug therapy market.